MedTrace Logo

Cryoablation for Monomorphic Ventricular Tachycardia (VTS)

NCT07650032 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-08-12

No results posted yet for this study

Summary

The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio Medical vCLAS Ventricular Ablation System (including VTS Catheter and Console) in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)

Conditions

  • Ventricular Tachycardia, Sustained
  • Ventricular Tachycardia, Monomorphic

Interventions

DEVICE

Ultra Low Temperature Ablation (ULTA)

ablation procedure using the investigational device (vCLAS Ventricular Ablation System including VTS Catheter and Console)

Sponsors & Collaborators

  • Adagio Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2027-03-31
Completion
2027-09-30
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07650032 on ClinicalTrials.gov